Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2026-05-09 @ 4:12 PM
Study NCT ID:
NCT06156332
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-05
First Post:
2023-11-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy
Sponsor:
Shanghai Changzheng Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumors With Neuroendocrine Differentiation | View |
Keywords: